Leaderboards/cholangiocarcinoma and gallbladder cancer studies

cholangiocarcinoma and gallbladder cancer studies

Last updated June 2, 2026

Rising Stars

New and hot

Rising Stars Researchers

1
James J. Harding
Memorial Sloan Kettering Cancer Center
99
2
Junji Furuse
Kanagawa Prefectural Hospital Organization
90
3
Kouji Yamamoto
Yokohama City University
80
4
Shubham Pant
The University of Texas MD Anderson Cancer Center
70
5
Vindhya Vijay
Broad Institute
60
6
Quynh Thi Vu
Okayama University
40
7
Toshihiro Koyama
Okayama University
30
8
Do‐Youn Oh
Seoul National University Hospital
10

Rising Stars Papers

1
Immunomodulatory effects of trastuzumab deruxtecan through the cGAS-STING pathway in gastric cancer cells
Cell Communication and Signaling|2024
18 cit.
2
Therapeutic potential of BOLD-100, a GRP78 inhibitor, enhanced by ATR inhibition in pancreatic ductal adenocarcinoma
Cell Communication and Signaling|2025
4 cit.
3
JPI-547, a Dual Inhibitor of PARP/Tankyrase, Shows Antitumor Activity Against Pancreatic Cancers with Homologous Recombination Repair Deficiency or Wnt-Addiction
International Journal of Biological Sciences|2025
3 cit.
4
YAP as a therapeutic target to reverse trastuzumab resistance
Gastric Cancer|2025
0 cit.
5
Supplementary data1 from First-in-Human Phase I/II Study of INCAGN01876, a Glucocorticoid-Induced Tumor Necrosis Factor Receptor Agonist, in Patients with Advanced or Metastatic Solid Tumors
Unknown Journal|2025
0 cit.

Emerging Leaders

Gaining momentum

Emerging Leaders Researchers

1
B. Ten Haaft
Amsterdam University Medical Centers
90
2
Shubham Pant
The University of Texas MD Anderson Cancer Center
80
3
Cecilia Binda
Azienda-Unita' Sanitaria Locale Di Cesena
70
4
Daniela Tataru
NHS Digital
50
5
Michinori Matsumoto
Jikei University School of Medicine
30
6
Jieer Ying
Zhejiang Cancer Hospital
20
7
Mariana Yáñez-Bartolomé
Hebron University
10

Emerging Leaders Papers

1
Chebulagic acid suppresses gastric cancer by inhibiting the AURKA/β-catenin/Wnt pathway
Frontiers in Pharmacology|2023
10 cit.
2
A benzochalcone derivative synchronously induces apoptosis and ferroptosis in pancreatic cancer cells
PeerJ|2023
3 cit.

All-Time Leaders

The canon

All-Time Leaders Researchers

1
John Bridgewater
Cancer Institute (WIA)
99
2
Alastair D. Smith
Duke Medical Center
90
3
Gregory J. Gores
Mayo Clinic in Arizona
80
4
Hans J. Schlitt
University Hospital Regensburg
70
5
Dirk Arnold
Asklepios Klinik Altona
60
6
Fareeda Y. Coxon
CRUK Lung Cancer Centre of Excellence
50
7
Soon‐Ae Shin
Inje University
40
8
Malcolm J. Moore
University Health Network
30
9
Setsuo Hirohashi
Unknown
20
10
Yuji Nimura
Nagoya University
10

All-Time Leaders Papers

1
Cholangiocarcinoma 2020: the next horizon in mechanisms and management
Nature Reviews Gastroenterology & Hepatology|2020
2.4k cit.
2
Cholangiocarcinoma
Nature Reviews Disease Primers|2021
830 cit.
3
Prognostic and predictive value of primary tumour side in patients with RAS wild-type metastatic colorectal cancer treated with chemotherapy and EGFR directed antibodies in six randomized trials
Annals of Oncology|2017
829 cit.
4
Free Fatty Acids Induce JNK-dependent Hepatocyte Lipoapoptosis
Journal of Biological Chemistry|2006
718 cit.
5
Lysosomes in cell death
Oncogene|2004
709 cit.
6
Cholangiocarcinoma
Hepatology|2008
689 cit.
7
Genetic Alteration of Keap1 Confers Constitutive Nrf2 Activation and Resistance to Chemotherapy in Gallbladder Cancer
Gastroenterology|2008
471 cit.
8
Intracellular pH during "chemical hypoxia" in cultured rat hepatocytes. Protection by intracellular acidosis against the onset of cell death.
Journal of Clinical Investigation|1989
260 cit.
9
Akt phosphorylation is a risk factor for early disease recurrence and poor prognosis in hepatocellular carcinoma
Cancer|2004
224 cit.
10
JNK1-dependent PUMA Expression Contributes to Hepatocyte Lipoapoptosis
Journal of Biological Chemistry|2009
189 cit.

Indexing cholangiocarcinoma and gallbladder cancer studies Reagents

Citation data for reagents in this field is currently compiling.